Call to arrange a consultation
+1 416 777 0888

Genentech Inc. v Pfizer Canada Inc.

2018
T-317-18
Resolved
New PM(NOC) Regulations

Motion/Application under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)

Counsel to: 
Pfizer Canada Inc.
here.

Meet the team

Arrow down